FAKTOR YANG MEMPENGARUHI KEGAGALAN PROSEDUR PLASMAFERESIS PADA PENDONOR PLASMA KONVALESEN DI UTD PMI KOTA YOGYAKARTA
Abstract
Keywords
Full Text:
PDFReferences
C. Sohrabi et al., “World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19),†International Journal of Surgery. 2020. doi:10.1016/j.ijsu.2020.02.034.
C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,†The Lancet, 2020, doi: 10.1016/S0140-6736(20)30183-5.
W. H. Huang et al., “2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China,†Journal of Microbiology, Immunology and Infection, 2020, doi:
1016/j.jmii.2020.02.009.
M. Zhou, X. Zhang, and J. Qu, “Coronavirus disease 2019 (COVID-19): a clinical update,†Frontiers of medicine. 2020. doi: 10.1007/s11684-020-0767-8.
World Health Organization (WHO), “WHO Coronavirus Disease (COVID-19) Dashboard.†2020.
S. P. Covid-19, “No Title.†2020.
F. Zeng, X. Chen, and G. Deng, “Convalescent plasma for patients with COVID-19,†Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 23, p. 12528, 2020, doi: 10.1073/pnas.2006961117.
H. S. H. Houng, D. Norwood, G. V. Ludwig, W. Sun, M. Lin, and D. W. Vaughn, “Development and evaluation of an efficient 3′-noncoding region based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV infections,†Journal of Virological Methods, 2004, doi: 10.1016/j.jviromet.2004.04.008.
C. Shen et al., “Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma,†JAMA - Journal of the American Medical Association, 2020, doi: 10.1001/jama.2020.4783.
M. Shen et al., “Recent advances and perspectives of nucleic acid detection for coronavirus,†Journal of Pharmaceutical Analysis. 2020. doi: 10.1016/j.jpha.2020.02.010.
Menteri Kesehatan, Peraturan Menteri Kesehatan RI No 91 Tahun 2015 tentang Standar Pelayanan Transfusi Darah. Jakarta, 2015. Accessed: Jan. 01, 2022. [Online]. Available: http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No._91_ttg_Standar_Transfusi_Pelayanan_Darah_.pdf
M. S. Maulana, “EFEKTIVITAS EFIKASI PEMBERIAN TERAPI KONVALESEN PLASMA PADA PASIEN COVID-19 : EVIDENCE BASED CASE REPORT,†Jurnal Kedokteran dan Kesehatan : Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya, vol.7, no. 3, pp. 7–14, Oct. 2020, doi: 10.32539/jkk.v7i3.12297.
M. Ye et al., “Treatment with convalescent plasma for COVID-19 patients in Wuhan, China,†Journal of Medical Virology, 2020, doi: 10.1002/jmv.25882.
C. Shen et al., “Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma,†JAMA - Journal of the American Medical Association, vol. 323, no. 16, pp. 1582–1589, 2020, doi: 10.1001/jama.2020.4783.
Y. Cheng et al., “Use of convalescent plasma therapy in SARS patients in Hong Kong,†no. March 2003, pp. 44–46, 2005, doi: 10.1007/s10096-004-1271-9.
F. R. S. Supadmi, T. D. E. Susilo, and N. Mumpuni, “Literatur Review: Terapi Plasma Konvalesen bagi Pasien Covid-19,†Jurnal Medica Arteriana, vol. 3, no. 1, pp. 53–61, 2021, Accessed: Dec. 20, 2021. [Online]. Available: https://jurnal.unimus.ac.id/index.php/MedArt/article/view/7586
J. F. W. Chan et al., “Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan,†Emerging Microbes and Infections, vol. 9, no. 1, pp. 221–236, 2020, doi: 10.1080/22221751.2020.1719902.
R. A. Khailany, M. Safdar, and M. Ozaslan, “Genomic characterization of a novel SARS-CoV2,†Gene Reports, 2020, doi: 10.1016/j.genrep.2020.100682.
R. S. E. Gantini et al., PROTOKOL PENYIAPAN PLASMA KONVALESEN UNTUK TERAPI COVID-19 DI UNIT DONOR DARAH PALANG MERAH INDONESIA, 1st ed. Jakarta: Unit Donor Darah Pusat Palang Merah Indonesia, 2020.
Refbacks
- There are currently no refbacks.
Prosiding Seminar Nasional
Universitas Respati Yogyakarta
Fax : 0274-489780
This work is licensed under a Creative Commons Attribution 4.0 International License.